Halogen bonding for rational drug design and new drug discovery
The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: A large number of drugs and drug candidates in clinical development contain halogen substituents. For a long time, only the steric and lipophilic contributions of halogens were considered when trying to exploit their effects on ligand binding. However, the ability of halogens to form stabilizing interactions, such as halogen bonding, hydrogen bonding and multipolar interactions, in biomolecular systems was revealed recently. Halogen bonding, the non-covalent interaction in which covalently bound halogens interact with Lewis bases, has now been utilized in the context of rational drug design. AREAS COVERED: The purpose of this review is to show how halogen bonding could be used in drug design, and in particular, to stimulate researchers to apply halogen bonding in lead optimization. This review article covers the recent advances relevant to halogen bonding in drug discovery and biological design over the past decade, including database survey of this interaction in protein-ligand complexes, molecular mechanical investigations of halogen bonding in drug discovery and applications of this interaction in the development of halogenated ligands as inhibitors and drugs for protein kinases, serine protease factor Xa, HIV reverse transcriptase and so on. EXPERT OPINION: Halogen bonding should intentionally be used as a powerful tool, comparable with hydrogen bonding, to enhance the binding affinity and also influence the binding selectivity. Rational design of new and potent inhibitors against therapeutic targets through halogen bonding continues to be an exciting area, which will be further elucidated with the combination of various experimental techniques and theoretical calculations in the forthcoming years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
An introduction to hydrogen bonding
(1998) · Choice Reviews Online · doi:10.5860/choice.35-3309 · Cited by 6,199
Interactions with Aromatic Rings in Chemical and Biological Recognition
Meyer, E. A., Castellano, R. K., & Diederich, F. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390319 · Cited by 3,541
Clark, T., Hennemann, M., Murray, J. S., & Politzer, P. (2007) · Journal of Molecular Modeling · doi:10.1007/s00894-006-0130-2 · Cited by 2,314
Protein kinases — the major drug targets of the twenty-first century?
Cohen, P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd773 · Cited by 2,186
Halogen Bonding Based Recognition Processes: A World Parallel to Hydrogen Bonding
Metrangolo, P., Neukirch, H., Pilati, T., & Resnati, G. (2005) · Accounts of Chemical Research · doi:10.1021/ar0400995 · Cited by 1,915
A Medicinal Chemist’s Guide to Molecular Interactions
Bissantz, C., Kuhn, B., & Stahl, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100112j · Cited by 1,731
Theory of Intermolecular Forces
(1969) · Elsevier eBooks · doi:10.1016/c2013-0-02436-x · Cited by 1,680
Halogen bonds in biological molecules
Auffinger, P., Hays, F. A., Westhof, E., & Ho, P. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407607101 · Cited by 1,634
Halogen Bonding in Supramolecular Chemistry
Metrangolo, P., Meyer, F., Pilati, T., Resnati, G., & Terraneo, G. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800128 · Cited by 1,605
Halogen bonding: an electrostatically-driven highly directional noncovalent interaction
Politzer, P., Murray, J. S., & Clark, T. (2010) · Physical Chemistry Chemical Physics · doi:10.1039/c004189k · Cited by 1,580
Aromatic Rings in Chemical and Biological Recognition: Energetics and Structures
Salonen, L. M., Ellermann, M., & Diederich, F. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007560 · Cited by 1,539
The Theory of Intermolecular Forces
Stone, A. J. (1996) · doi:10.1093/oso/9780198558842.001.0001 · Cited by 1,482
An overview of halogen bonding
Politzer, P., Lane, P., Concha, M. C., Ma, Y., & Murray, J. S. (2007) · Journal of Molecular Modeling · doi:10.1007/s00894-006-0154-7 · Cited by 1,429
Eriksson, A. E., Baase, W. A., Zhang, X. J., Heinz, D. W., Blaber, M., Baldwin, E. P., & Matthews, B. W. (1992) · Science · doi:10.1126/science.1553543 · Cited by 919
Expansion of the σ-hole concept
Murray, J. S., Lane, P., & Politzer, P. (2009) · Journal of Molecular Modeling · doi:10.1007/s00894-008-0386-9 · Cited by 754
Halogen atoms in the modern medicinal chemistry: hints for the drug design
Hernandes, M., Cavalcanti, S. M., Moreira, D. R., de Azevedo Junior, W., & Leite, A. C. (2010) · Current Drug Targets · doi:10.2174/138945010790711996 · Cited by 723
Putting Anion–π Interactions Into Perspective
Frontera, A., Gamez, P., Mascal, M., Mooibroek, T. J., & Reedijk, J. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201100208 · Cited by 671
The halogen bond: an interim perspective
Legon, A. C. (2010) · Physical Chemistry Chemical Physics · doi:10.1039/c002129f · Cited by 605
Lone Pair−Aromatic Interactions: To Stabilize or Not to Stabilize
Egli, M., & Sarkhel, S. (2007) · Accounts of Chemical Research · doi:10.1021/ar068174u · Cited by 587
Halogen Bonding—A Novel Interaction for Rational Drug Design?
Lu, Y., Shi, T., Wang, Y., Yang, H., Yan, X., Luo, X., Jiang, H., & Zhu, W. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9000133 · Cited by 559
Self-citationPharmacological inhibitors of cyclin-dependent kinases
Knockaert, M., Greengard, P., & Meijer, L. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02071-0 · Cited by 537
Orthogonal Multipolar Interactions in Structural Chemistry and Biology
Paulini, R., Müller, K., & Diederich, F. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200462213 · Cited by 505
Systematic Investigation of Halogen Bonding in Protein–Ligand Interactions
Hardegger, L. A., Kuhn, B., Spinnler, B., Anselm, L., Ecabert, R., Stihle, M., Gsell, B., Thoma, R., Diez, J., Benz, J., et al. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006781 · Cited by 492
Halogen bonding: a general route in anion recognition and coordination
Cavallo, G., Metrangolo, P., Pilati, T., Resnati, G., Sansotera, M., & Terraneo, G. (2010) · Chemical Society Reviews · doi:10.1039/b926232f · Cited by 472
Halogen bonding in halocarbon–protein complexes: a structural survey
Parisini, E., Metrangolo, P., Pilati, T., Resnati, G., & Terraneo, G. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00177e · Cited by 443
Halogen bonded supramolecular complexes and networks
Rissanen, K. (2008) · CrystEngComm · doi:10.1039/b803329n · Cited by 424
Metrangolo, P., & Resnati, G. (2008) · Science · doi:10.1126/science.1162215 · Cited by 422
Halogen bonds as orthogonal molecular interactions to hydrogen bonds
Voth, A. R., Khuu, P., Oishi, K., & Ho, P. S. (2009) · Nature Chemistry · doi:10.1038/nchem.112 · Cited by 411
Lu, Y., Wang, Y., & Zhu, W. (2010) · Physical Chemistry Chemical Physics · doi:10.1039/b926326h · Cited by 394
Self-citationHalogen bonding in metal–organic–supramolecular networks
Bertani, R., Sgarbossa, P., Venzo, A., Lelj, F., Amati, M., Resnati, G., Pilati, T., Metrangolo, P., & Terraneo, G. (2010) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.09.035 · Cited by 364
Politzer, P., Murray, J. S., & Concha, M. C. (2007) · Journal of Molecular Modeling · doi:10.1007/s00894-007-0176-9 · Cited by 362
Directing macromolecular conformation through halogen bonds
Voth, A. R., Hays, F. A., & Ho, P. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610531104 · Cited by 350
Chudzinski, M. G., McClary, C. A., & Taylor, M. S. (2011) · Journal of the American Chemical Society · doi:10.1021/ja202096f · Cited by 293
Matter, H., Nazaré, M., Güssregen, S., Will, D. W., Schreuder, H., Bauer, A., Urmann, M., Ritter, K., Wagner, M., & Wehner, V. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200806219 · Cited by 274
A cavity-containing mutant of T4 lysozyme is stabilized by buried benzene
Eriksson, A. E., Baase, W. A., Wozniak, J. A., & Matthews, B. W. (1992) · Nature · doi:10.1038/355371a0 · Cited by 266
Directional Weak Intermolecular Interactions: σ-Hole Bonding
Murray, J. S., Riley, K. E., Politzer, P., & Clark, T. (2010) · Australian Journal of Chemistry · doi:10.1071/ch10259 · Cited by 251
The fluorine atom as a halogen bond donor, viz. a positive site
Metrangolo, P., Murray, J. S., Pilati, T., Politzer, P., Resnati, G., & Terraneo, G. (2011) · CrystEngComm · doi:10.1039/c1ce05554b · Cited by 247
Ditopic Ion Transport Systems: Anion–π Interactions and Halogen Bonds at Work
Vargas Jentzsch, A., Emery, D., Mareda, J., Metrangolo, P., Resnati, G., & Matile, S. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201104966 · Cited by 243
Engineering functional materials by halogen bonding
Metrangolo, P., Resnati, G., Pilati, T., Liantonio, R., & Meyer, F. (2007) · Journal of Polymer Science Part A: Polymer Chemistry · doi:10.1002/pola.21725 · Cited by 226
Molecular mechanical study of halogen bonding in drug discovery
Ibrahim, M. A. A. (2011) · Journal of Computational Chemistry · doi:10.1002/jcc.21836 · Cited by 223
Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing
Fedorov, O., Huber, K., Eisenreich, A., Filippakopoulos, P., King, O., Bullock, A. N., Szklarczyk, D., Jensen, L. J., Fabbro, D., Trappe, J., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.11.009 · Cited by 204
Bogoyevitch, M. A. (2006) · BioEssays · doi:10.1002/bies.20458 · Cited by 188
The Role of Halogen Bonding in Inhibitor Recognition and Binding by Protein Kinases
Andrea, V., & P., H. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607781696846 · Cited by 163
Himmel, D. M., Das, K., Clark, A. D., Hughes, S. H., Benjahad, A., Oumouch, S., Guillemont, J., Coupa, S., Poncelet, A. J., Csoka, I., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0500323 · Cited by 150
Halogen Bonds Form the Basis for Selective P-TEFb Inhibition by DRB
Baumli, S., Endicott, J., & Johnson, L. N. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.07.012 · Cited by 144
Hardegger, L. A., Kuhn, B., Spinnler, B., Anselm, L., Ecabert, R., Stihle, M., Gsell, B., Thoma, R., Diez, J., Benz, J., et al. (2011) · ChemMedChem · doi:10.1002/cmdc.201100353 · Cited by 131
Xu, Z., Liu, Z., Chen, T., Chen, T., Wang, Z., Tian, G., Shi, J., Wang, X., Lu, Y., Yan, X., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200644r · Cited by 125
Self-citationBattistutta, R., Mazzorana, M., Sarno, S., Kazimierczuk, Z., Zanotti, G., & Pinna, L. A. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.08.015 · Cited by 118
Protein Kinase CK2 in Health and Disease
Battistutta, R. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-9155-x · Cited by 95
C−X···H Contacts in Biomolecular Systems: How They Contribute to Protein−Ligand Binding Affinity
Lu, Y., Wang, Y., Xu, Z., Yan, X., Luo, X., Jiang, H., & Zhu, W. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp906352e · Cited by 94
Self-citationHalogen bonding in ligand–receptor systems in the framework of classical force fields
Rendine, S., Pieraccini, S., Forni, A., & Sironi, M. (2011) · Physical Chemistry Chemical Physics · doi:10.1039/c1cp22436k · Cited by 87
Liu, L., Baase, W. A., & Matthews, B. W. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.086 · Cited by 87
Dobeš, P., Řezáč, J., Fanfrlík, J., Otyepka, M., & Hobza, P. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp202149z · Cited by 84
Refetoff, S. (1993) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30426-8 · Cited by 76
Matter, H., Will, D. W., Nazaré, M., Schreuder, H., Laux, V., & Wehner, V. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049187l · Cited by 70
Kraut, D. A., Churchill, M., Dawson, P. E., & Herschlag, D. (2009) · ACS Chemical Biology · doi:10.1021/cb900016q · Cited by 59
Role of Halogen Bonds in Thyroid Hormone Receptor Selectivity: Pharmacophore-Based 3D-QSSR Studies
Valadares, N. F., Salum, L. B., Polikarpov, I., Andricopulo, A. D., & Garratt, R. C. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900316e · Cited by 58
Assaying the Energies of Biological Halogen Bonds
Carter, M., & Ho, P. S. (2011) · Crystal Growth & Design · doi:10.1021/cg200991v · Cited by 48
Benjahad, A., Guillemont, J., Andries, K., Nguyen, C. H., & Grierson, D. S. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.045 · Cited by 36
Ibrahim, M. A. A. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci2002582 · Cited by 35
Shi, Y., Sitkoff, D. F., Zhang, J., Klei, H. E., Kish, K., Liu, E. C. ‐., Hartl, K. S., Seiler, S. M., Chang, M., Huang, C., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800855x · Cited by 34
Kinase Inhibition that Hinges on Halogen Bonds
Grant, S. K., & Lunney, E. A. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.01.003 · Cited by 17
Cited by
Cavallo, G., Metrangolo, P., Milani, R., Pilati, T., Priimagi, A., Resnati, G., & Terraneo, G. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00484 · Cited by 4,035
The Bright Future of Unconventional σ/π‐Hole Interactions
Bauzá, A., Mooibroek, T. J., & Frontera, A. (2015) · ChemPhysChem · doi:10.1002/cphc.201500314 · Cited by 710
Halogen Bond: Its Role beyond Drug–Target Binding Affinity for Drug Discovery and Development
Xu, Z., Yang, Z., Liu, Y., Lu, Y., Chen, K., & Zhu, W. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400539q · Cited by 431
Self-citationDevelopment of Halogenase Enzymes for Use in Synthesis
Latham, J., Brandenburger, E., Shepherd, S. A., Menon, B. R. K., & Micklefield, J. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00032 · Cited by 358
Kubillus, M., Kubař, T., Gaus, M., Řezáč, J., & Elstner, M. (2015) · Journal of Chemical Theory and Computation · doi:10.1021/ct5009137 · Cited by 303
Metadata
- Authors
- Lu, Y., Liu, Y., Xu, Z., Li, H., Liu, H., & Zhu, W.
- Venue
- Expert Opinion on Drug Discovery
- Publisher
- Informa UK Limited
- Published
- 2012-03-30
- Volume
- 7
- Issue
- 5
- Pages
- 375-383
- ISSN
- 1746-0441 (ISSN-L)
- 1746-045X
- OpenAlex
- W2166845515
- Cited by
- 318
- References
- 63
- FWCI
- 12.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.